Compugen (CGEN) Total Non-Current Liabilities (2009 - 2026)

Compugen (CGEN) reported Total Non-Current Liabilities of $28.5 million for Q1 2026, down 23.76% on a YoY basis from $37.3 million in Q1 2025, and down 8.95% sequentially from $31.3 million in Q4 2025.

Compugen (CGEN) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Compugen (CGEN) has 18 years of Total Non-Current Liabilities data on file, last reported at $28.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities fell 23.76% year-over-year to $28.5 million; the trailing twelve-month figure through Mar 2026 stood at $28.5 million (down 23.76% YoY), and the FY2025 full-year result was $31.3 million, down 21.67% from the prior year.
  • Total Non-Current Liabilities slipped to $28.5 million in Q1 2026, from $31.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $39.9 million in Q4 2024 to a low of $4.0 million in Q3 2023.
  • A 5-year average of $21.3 million and a median of $28.5 million in 2026 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities sank 45.34% in 2022 and surged 779.92% in 2024, its largest moves.
  • Tracing CGEN's Total Non-Current Liabilities over 5 years: stood at $4.6 million in 2022, then soared by 544.72% to $29.5 million in 2023, then surged by 35.28% to $39.9 million in 2024, then retreated by 21.67% to $31.3 million in 2025, then fell by 8.95% to $28.5 million in 2026.
  • Business Quant data shows CGEN's Total Non-Current Liabilities at $28.5 million in Q1 2026, $31.3 million in Q4 2025, and $33.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Compugen 221.26 Mn 129.51 Mn 352,000.00 28.47 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28.47 Mn
Dec 31, 2025 31.27 Mn
Sep 30, 2025 33.74 Mn
Jun 30, 2025 35.69 Mn
Mar 31, 2025 37.34 Mn
Dec 31, 2024 39.92 Mn
Sep 30, 2024 35.27 Mn
Jun 30, 2024 27.06 Mn
Mar 31, 2024 29.40 Mn
Dec 31, 2023 29.51 Mn
Sep 30, 2023 4.01 Mn
Jun 30, 2023 4.25 Mn
Mar 31, 2023 4.39 Mn
Dec 31, 2022 4.58 Mn
Sep 30, 2022 4.78 Mn
Jun 30, 2022 5.94 Mn
Mar 31, 2022 7.08 Mn
Dec 31, 2021 8.37 Mn
Sep 30, 2021 7.22 Mn
Jun 30, 2021 7.55 Mn